* Medpace Holdings Inc MEDP.OQ MEDP.O is expected
to show a
rise in quarterly revenue when it reports results
* The Cincinnati Ohio-based company is expected to report
a
24.0% increase in revenue to $475.751 million from $383.74
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Medpace Holdings
Inc is
for earnings of $2.05 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medpace
Holdings
Inc is $270, above its last closing price of $229.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 1.91 1.91 1.93 Beat 0.8
Mar. 31 2023 1.80 1.80 2.27 Beat 26
Dec. 31 2022 1.79 1.79 2.12 Beat 18.7
Sep. 30 2022 1.48 1.47 2.05 Beat 39.1
Jun. 1.33 1.31 1.46 Beat 11.3
30 2022
Mar. 31 2022 1.26 1.26 1.69 Beat 34
Dec. 31 2021 1.25 1.25 1.32 Beat 5.5
Sep. 30 2021 1.08 1.07 1.29 Beat 20.1
This summary was machine generated October 20 at 23:18 GMT. All
figures in US dollars unless otherwise stated